Further studies from Chan Kim et al. certified that RHOJ blockade is an effective and selective strategy for tumor angiogenesis and vascular disruption, and also showed that it has the advantages of good curative effect, high specificity, and mild toxic side effects 27. This evidence concerns the gene RHOJ and neoplasm.